|
|
|
市場調查報告書
|
本報告已在2012年04月11日停止出版。
更改為出版
Imaging Agents
出版日期 : 2012年02月
商品編碼: 236838
本報告書內容包括:全球的顯影劑市場的調查分析、顯影劑（X線、MRI、超音波）、診斷用放射性醫藥品的各產品彙整、美國、加拿大、日本、歐洲、亞太地區、中東、拉丁美洲的各國市場總體分析。此外、2007∼2015年為止的展望和過去7年間的實績等、主要內容綱要摘記如下:
目錄
第1章 介紹、調查方法、產品的定義
第2章 業界概觀
- 醫療用顯影劑市場的不景氣影響
- 未來的展望
- MRI標的影像 - 是否會帶來大變革？
- 發展中國家促進成長
- 何謂顯影劑
- 動態的變化
- 顯影劑 - 大幅成長的展望
- 非電離顯影技術的提升
- 價格變動的力學
- 診療報酬
第3章 市場趨勢和問題點
- 價格下滑的壓力
- 縮小X線顯影劑市場
- 成為主力的MRI顯影劑市場
- MRI的擴大使用所帶來的影響
- 有期望的超音波顯影劑市場
- 陽電子CT（PET） - 放射性醫藥品市場的牽引角色
- 核子醫學 - 潛在的成長領域中之放射線醫藥品
第4章 競争
- 市場結構
- 新興MRI市場的實力者
- Bayer Schering Pharma AG
- 競爭情境
第5章 技術的飛躍性進步
第6章 產品概觀
第7章 關於各產品領域
第8章 技術的動態
第9章 產品發行
第10章 最近的業界趨勢
第11章 最近的企業趨勢
第12章 最近的產品發行
第13章 主要企業
第14章 全球市場的展望
第15章 美國
第16章 加拿大
第17章 日本
第18章 歐洲
- 法國
- 德國
- 義大利
- 英國
- 西班牙
- 俄羅斯
- 其他歐洲各國
第19章 亞太地區
第20章 中東
第21章 拉丁美洲
競爭企業介紹
Abstract
This report analyzes the worldwide markets for Imaging Agents in US$ Million
by the following product segments - Contrast Media (X-Ray, MRI, & Ultrasound),
and Diagnostic Radiopharmaceuticals. The report provides separate
comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific,
Middle East, and Latin America. Annual estimates and forecasts are provided
for each region for the period 2007 through 2015. Also, a seven-year historic
analysis is provided for these markets. The report profiles 55 companies
including many key and niche players such as AMAG Pharmaceuticals Inc., Bayer
Schering Pharma AG, Bracco Group, Covidien, Cytogen Corp., Daiichi Sankyo
Company Limited, Eisai Co., Ltd, GE Healthcare, Guerbet Group, and Lantheus
Medical Imaging. Market data and analytics are derived from primary and
secondary research. Company profiles are mostly extracted from URL research
and reported select online sources.
Table of Contents
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- A. Contrast Media
- X-Ray Contrast Media
- Magnetic Resonance Imaging (MRI) Contrast Media
- Ultrasound Contrast Media
- B. Diagnostic Radiopharmaceuticals
2. INDUSTRY OVERVIEW
- Medical Imaging Industry Under the Impact of Economic Downturn
- Future Prospects
- Targeted MRI Imaging - A Game Changer in the Making?
- Developing Countries to Spur Growth
- A Quick Primer On Imaging Agents
- Growth Drivers
- Growth Inhibitors
- Changing Dynamics of Imaging Agents
- Imaging Agents: Significant Growth Ahead
- Rise of Non-Ionizing Imaging Techniques
- Fusion Imaging Modalities: Greater Clinical Benefits
- Radioactive Isotopes Utilized in PET & SPECT Imaging Procedures
- Radiopharmaceuticals-An Exotic Tool
- Nanomaterials Taking the Center Stage
- Gadolinium Coated Nanoparticles- A Promising Imaging Agent
- A Peek Into Pricing Dynamics
- A Synoptic Overview
- Pros & Cons
- Positive Factors Driving Prices
- Negative Factors Bearing Down on Prices
- Reimbursements
- "Under the Umbrella"
- Europe
- United States
3. MARKET TRENDS & ISSUES
- Falling Prices Turn On the Heat
- X-Ray Contrast Media: Declining Sector
- MRI Contrast Media: Playing at Center Court
- Impact Wielded by Ballooning MRI Practices
- Ultrasound Contrast Media: A Rising Star in the Quadrant
- Fledging Market Battles Teething Challenges
- PET: A Prime Growth Driver for Radiopharmaceuticals
- Nuclear Medicine: A Potential Growth Avenue for Radiopharmaceuticals
- Select Cardiology and Oncology Radiopharmaceuticals
4. COMPETITION
- Market Structure
- Big Guns in the Emerging MRI Market
- Bayer Schering Pharma AG: A Pioneering Developer of MRI Contrast Agents
- Competitive Scenario
- Table 1: Worldwide Imaging Agents Market (2009E): Percentage
Breakdown of Value Sales for Leading Players- GE Healthcare, Bracco,
Covidien, Bayer Schering Pharma, and Others (includes corresponding
Graph/Chart)
- Table 2: X-ray Medical Contrast Media Market Worldwide (2009E):
Percentage Breakdown of Sales for GE Healthcare, Bracco, Covidien, Bayer
Schering Pharma and Others (includes corresponding Graph/Chart)
- Table 3: MRI Contrast Media Market Worldwide (2009): Percentage
Breakdown of Sales for Bayer Schering Pharma, GE Healthcare, Bracco,
Covidien and Others (includes corresponding Graph/Chart)
- Table 4: Radiopharmaceutical Contrast Media Market Worldwide:
Percentage Share of Leading Players for 2007 - GE Healthcare, Bristol-Myers
Squibb, Mallinckrodt/ Covidien, MDS Nordion and Others (Revenue Share)
(includes corresponding Graph/Chart)
5. TECHNOLOGY BREAKTHROUGHS
- Molecular Imaging Agents: The Outer Limits
- On Cards: Hyperpolarized Gases as Contrast Agents
- Imaging Agents Make a Welcome Impact in the Field of Alzheimer' s Disease
- Technetium-99m: A Breakthrough Contrast Agent for CNS Imaging
- A New Imaging Agent for Radiopharmaceutical Scans
- Multi-Modal Image Registration: Combating Contrast Medium Inconsistencies
- Saline Flushes To Help Ensure Accurate Delivery of Contrast Agents
6. PRODUCT OVERVIEW
- Contrast Agents
- Contrast Media: How Do They Function?
- Where Are They Used...?
- Evolution of Contrast Media: A Profile
- Bismuth Nitrate: Beginning of Contrast Agents
- Imaging Agents: Significant Developments in the Last Fifty Years
- Schering Develops First Intravenous Contrast Agent
- MRI: Creating a New Era for Contrast Agents
- A Peek into the Finer Points of Differences Among Contrast Media
- Viscosity
- Osmolality
- Chemotoxicity
- Second Generation Non-Ionic Contrast Agents: An Introduction
- Choice of the Contrast Medium: A Weighty Decision
- Factors affecting choice of Imaging Agents
- Taxonomy
- Types of Contrast Media
- X-Ray Contrast Medium
- First Generation High Osmolar Contrast Media
- Second Generation Low Osmolar Contrast Media or LOCM
- Table 5: Comparative Analysis of Structure of Non-ionic and ionic
X-ray Contrast Media
- MRI Contrast Medium
- Role of Contrast Enhancement in MR Angiography (MRA)
- MRI Contrast Agents for the Liver
- Paramagnetic extracellular contrast agents
- Hepatobiliary Gadolinium Chelates
- Superparamagnetic Iron Oxide Particles
- Ultrasound Contrast Medium
- Ultrasonographic Contrast Media: What Are They?
- Ultrasound Contrast Enhancement in Cardiology
- Functionalities of Vascular Ultrasound Contrast Agents
- Diagnostic Radiopharmaceuticals
- Key Radioactive Isotopes used as Diagnostic Radiopharmaceuticals
- A Delineate of Diagnostic Radiopharmaceuticals
- Diagnostic Radiopharmaceuticals: A Technical Run-Through
- Applications
7. A SEGMENTAL REVIEW
- Contrast Media
- Popular Brands of Contrast Agents
- X-ray Contrast Media
- Market Scenario
- MRI Contrast Media
- Market Scenario
- Ultrasound Contrast Media
- Market Overview
- Competitive Scenario
- Diagnostic Radiopharmaceuticals
- Market Overview
- Immunoconjugates
- Market Overview
- Competitive Scenario
8. TECHNOLOGY DYNAMICS
- Proprietary Technologies Making Significant In-Roads
- Advanced Magnetics' Proprietary Colloidal Superparamagnetic Particle
Technology
- Enzon' s Single Chain Antigen-Binding Technology
- Immunomedics' Antibody Technology
- First Generation
- Second Generation
- Third Generation
- NeoRx' s "Painting the Target" Technology
- Stage - I
- Stage - II
- Stage - III
- Gas Encapsulation Technology for Ultrasound Contrast Media
- Pharmacyclics' Texaphyrin Technology
- Regulatory Bodies
- Ultrasound Contrast Agents Are Drugs, Not Devices - Rules US FDA
- Entry Barriers
- Research Driven Markets
- Highly Competitive Market
- Economies of Scale
- Substitutes in Agents Manufacturing
- New X-ray Diagnostic Agents
- Amide-based Macrocyclic Ligands - Potential MRI Agents
- Gadolinium (III) Complexes - Potential MRI Contrast Agents
- Metal-Containing Compounds Act As Potential Contrast Agents
- Therapeutic Applications
- Diagnostic Applications
- Magnetic Gels as Potential MRI Contrast Agents
- PFCs as Diagnostic Contrast Agents
9. PRODUCT LAUNCHES
- GE Healthcare Receives FDA Approval for DaTscan for detecting Dopamine
Transporters
- Targeson Launches Targestar® P-HF
- GE Healthcare Announces Phase II Study Results of Flutemetamol, the PET
Imaging Agent for Brain Imaging
- GE Healthcare Receives FDA Approval for Cysview, An Optical Imaging Agent
for Cystoscopic Detection of Papillary Bladder Cancer
- INER Develops Imaging Agents for Cerebral Blood Flow
- Lantheus Medical Imaging Introduces Definity Ultrasound Contrast Imaging
Agent in India
- Sanochemia Pharmazeutika Completes DCP Phase of MRT Imaging Agent, to
Introduce Within Major European Markets by 2011
- Bayer Transfers Liver MRI Contrast Medium Resovist Injection to I' rom
Pharmaceutical
- GE Healthcare Re-Introduces Contrast Agent, Optison™
- Lantheus Medical Imaging Introduces ABLAVAR™ in Canada
- VisEn Introduces ProSense® 750 FAST and Neutrophil Elastase™
680 FAST
- Bayer Works on Development of MR Contrast Agents for Breast Cancer
Diagnosis
- Lantheus Medical Imaging Introduces ABLAVAR™ MRA Imaging Agent
- VisEn Introduces Cat B 680 FAST™ Imaging Agent
- VisEn Medical Introduces GastroSense 750 Fluorescence Imaging Agent
- VisEn Medical Unveils VivoTag® 645 Red Fluorescent Dye
- VisEn Medical Launches VivoTag® 680 XL Fluorescent Dye
- AMAG Pharmaceuticals Unveils Superparamagnetic Iron Oxide Nanopaticles
- MabCure Unveils Monoclonal Antibodies
- VisEn Medical Introduces ReninSense680™ FAST
- VisEn Medical Introduces New VivoTag® 800 and OsteoSense® Imaging
Agents
- VisEn Medical Introduces Annexin-Vivo 750 Imaging Agent
- VisEn Introduces New Fluorescence Molecular Imaging Agent,
IntegriSense™ 750
- Bayer to Launch Primovist™ and Nexavar™ in Japan
- Sanochemia Unveils MR-Lux®
- VisEn Medical Introduces New Fluorescence in Vivo Imaging Agent,
IntegriSense
- Bayer to Unleash Radiology Management System
- Bayer to Unveil Pre-Filled Contrast-Medium Cartridges for MRI
10. RECENT INDUSTRY ACTIVITY
- University of Montana Receives Patents for Two New Brain Imaging Agents
- Eli Lilly Acquires Avid Radiopharmaceuticals
- GE Global Research Secures Multi-Year NIH Grant to Develop Nerve Imaging
Agent and Imaging System
- Agfa Healthcare Snaps Insight Agents
- Nordion to Divest MDS Nordion S.A.
- Sofie Biosciences Secures Funds for Research on Molecular PET Imaging
Agents
- Aposense Signs Collaboration Agreement With Roche
- University of Washington to Collaborate with Cardinal Health for
Advancement of Molecular Imaging
- ImaginAb Joins Hand with GE Imanet for Developmental Drug Research
- Cancer Targeted Technology Inks Agreement with Bayer Pharma for Cancer
PET Imaging Agent
- Lantheus Medical Imaging Wins Global Rights for Gadofosveset Trisodium
- Avid Radiopharmaceuticals Partners with Siemens PETNET Solutions for
Production of Florbetapir F 18
- VisEn Expands Fluorescence Imaging Intellectual Patent Portfolio through
Acquisition of Bayer Schering' s Portfolio
- Cardinal Health Enters into Partnership with ProVision for Cyclotrons
- Center for Diagnostic Imaging Sets up New Imaging Center
- ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL Biologics
- Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement for
Molybdenum-99
- Lantheus Medical Imaging Purchases MS-325 Related Rights from EPIX
Pharmaceuticals
- GE Healthcare Inks Agreement with Nycomed
- Photocure Secures Reimbursement Approval for Hexvix in Germany
- Agfa HealthCare to Acquire Insight Agents
- Eckert & Ziegler Disinvests FCI Contrast Media Business
- Guerbet Signs Distribution Agreement with Draximage for its Nuclear
Medicine Product Range
- ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL Biologics
- Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement for
Molybdenum-99
- Lantheus Medical Imaging Purchases MS-325 Related Rights for Select
Markets from EPIX Pharmaceuticals
- MDS Nordion, TRIUMF and University of British Columbia Enter into
Partnership
- Alseres Pharmaceuticals Signs Agreement for Special Protocol Assessment
of Altropane
- Pharmalucence Wins Approval from FDA for Sestamibi Kit
- Covidien Obtains Approval from Health Canada for Sestamibi Injection
- MDS Nordion Commences Production of CardioGen-82
- Avista Capital Partners Acquires Bristol-Myers Squibb Medical Imaging
- Amerinet Awards Contract to Bayer HealthCare
- Bristol-Myers Squibb Medical Imaging Changes Name to Lantheus Medical
Imaging
- Bayer Schering Secures FDA Marketing Clearance for Primovist®
- Bracco-Eisai Secures Approval for Iomeron® 350 and Iomeron® 350
Syringe for Use in Dynamic Liver CT
- Covidien Signs Co-Marketing Deal with PETNET over Nuclear Medicine
Therapies
- EPIX Receives FDA Approval for Vasovist
- GE Global and NCI Partner to Speed-up Development of Cancer and Heart
Disease Diagnosing Nanoparticle Imaging Agents
- Lantheus Wins Contract from PPP
- Sanguine to Take over Rockland
- Starpharma Holdings Enters into an Agreement with Unilever
- GE Healthcare and Cardinal Health Enter Into a Deal
- Jubilant to Take Over DRAXIS
- MTTI and Bexion to Partner for Nanovesicle
- Otsuka Takes over IPP
- Wilex Inks Deal with IBA
- Cytogen Corporation to Merge Business with EUSA Pharma Inc
- Bracco Group Acquires E-Z-EM
- EPIX Pharmaceuticals to Resubmit New Drug Application (NDA) for Vasovist
- Bayer Schering, FutureChem Ink Licensing Deal
- NuView Radio Pharmaceuticals Inks Agreement for Non- Invasive Imaging
Agent
11. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER
- Advanced Magnetics Inc Changes Name to AMAG Pharmaceuticals
- Bracco Diagnostics Inks Agreement with HealthTrust Purchasing Group
- Bracco Diagnostics Offers MRI Products to HealthTrust Purchasing Group
- Bayer HealthCare Offers MRI Contrast Agent to HealthTrust
- Bayer HealthCare Extends Contract with Premier
- Bayer HealthCare Sets Off US Operations
- Tyco Healthcare Renamed to Covidien Ltd
- Covidien Offers Imaging Solutions to MedAssets Supply Chain Systems
- Siemens, M.D. Anderson Cancer Center Set up Research Centre
- Bayer, Berlex Merge Operations
- AION Diagnostics Forays Pre-Clinical Imaging Agent Market
- ART Acquires Alerion Biomedical
- EPIX to Merge with Predix
- Fujifilm Acquires Stake in Daiichi Radioisotope Laboratories
- Bracco Diagnostics Inks Agreement with Amerinet
- Vasovist receives Green Signal in Australia
- AION Diagnostics Develops BioSilicon™
- Sonazoid Receives Import Approval
- Schering AG Divests Radiopharmaceutical Business to Ion Beam Applications
and Institut National des Radioéléments
- Vasovist Receives European Approval
- Albany Molecular Research Renews Supply Agreement with GE Healthcare
- QuantRx Biomedical Corp. Acquires Stake in FluoroPharma
- Palatin Technologies Withdraws NeutroSpec Imaging Agent
- Diosynth Bags Contract to Produce Imaging Agent
- GE Healthcare Signs Marketing Agreement with PhotoCure
- DRAXIMAGE Receives the Green Signal in Europe
- Daiichi and Sankyo Sign a Merger Deal
12. PRODUCT INTRODUCTIONS IN RECENT PAST - A PERSPECTIVE BUILDER
- Insight Agents to Launch Generic Contrast Media Solutions In Europe
- Researchers Develop First Biocompatible MRI Contrast Agent
- Signalomics and Invitrogen Collaborate to Develop Nanocrystal Reagents
- Schering AG Collaborates with Stanford University to Develop Molecular
Imaging Agent
- Schering and Avid to Develop Diagnostic Imaging Agents
- US National Institutes of Health Develops two PET Imaging Agents
13. FOCUS ON SELECT PLAYERS
- AMAG Pharmaceuticals, Inc. (USA)
- Bayer Schering Pharma AG (Germany)
- Bracco Group (Italy)
- Covidien (USA)
- Cytogen Corp. (USA)
- Daiichi Sankyo Company Limited (Japan)
- Eisai Co Ltd. (Japan)
- GE Healthcare (UK)
- Guerbet Group (France)
- Lantheus Medical Imaging (USA)
14. GLOBAL MARKET PERSPECTIVE
- Table 6: World Recent Past, Current & Future Analysis for Imaging
Agents by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 7: World Historic Review for Imaging Agents by Geographic Region
- US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East and
Latin American Markets Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 8: World 11-Year Perspective for Imaging Agents by Geographic
Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Latin America Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
- Table 9: World Recent Past, Current & Future Analysis for Contrast
Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 10: World Historic Review for Contrast Media by Geographic Region
- US, Canada, Japan, Europe, Asia- Pacific (excluding Japan), Middle East and
Latin American Markets Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 11: World 11-Year Perspective for Contrast Media by Geographic
Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Latin America Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
- Table 12: World Recent Past, Current & Future Analysis for Contrast
Media by Product Segments - X-Ray, MRI and Ultrasound Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 13: World Historic Review for Contrast Media by Product Segments
- X-Ray, MRI and Ultrasound Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart)
- Table 14: World 11-Year Perspective for Contrast Media by Product
Segments - Percentage Breakdown of Dollar Sales for X-Ray, MRI and Ultrasound
Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
- Table 15: World Recent Past, Current & Future Analysis for X-Ray
Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 16: World Historic Review for X-ray Contrast Media by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle
East and Latin American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart)
- Table 17: World 11-Year Perspective for X-Ray Contrast Media by
Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets
for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
- Table 18: World Recent Past, Current & Future Analysis for MRI
Contrast Media by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin America Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 19: World Historic Review for MRI Contrast Media by Geographic
Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle
East and Latin American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes corresponding
Graph/Chart)
- Table 20: World 11-Year Perspective for MRI Contrast Media by
Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets
for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
- Table 21: World Recent Past, Current & Future Analysis for
Ultrasound Contrast Media by Geographic Region - US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart)
- Table 22: World Historic Review for Ultrasound Contrast Media by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart)
- Table 23: World 11-Year Perspective for Ultrasound Contrast Media by
Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets
for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
- Table 24: World Recent Past, Current & Future Analysis for
Diagnostic Radiopharmaceuticals by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin America Markets
Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007
through 2015 (includes corresponding Graph/Chart)
- Table 25: World Historic Review for Diagnostic Radiopharmaceuticals by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin American Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart)
- Table 26: World 11-Year Perspective for Diagnostic Radiopharmaceuticals
by Geographic Region- Percentage Breakdown of Dollar Sales for US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East and Latin America
Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
15. THE UNITED STATES
- A. Market Analysis
- Outlook
- Imaging Centers Feel the Heat During Recession
- Growth Stimulants
- Dynamics of Pricing
- Diagnostic Radiopharmaceuticals
- Market Scenario
- Availability of Isotopes: A Tough Challenge
- Radiopharmaceuticals to Drive Growth
- Competitive Analysis - Imaging Market
- Reimbursement Issues
- Medicare
- Magnetic Resonance Imaging
- Regulatory Environment
- Provisions Regarding Off-Label Usage of Contrast Media
- Contrast Media
- X-ray Contrast Media
- MRI Contrast Media
- Market Scenario
- Managed Care Vs MRI Technology Diffusion
- Ultrasound Contrast Media
- B. Market Analytics
- Table 27: US Recent Past, Current & Future Analysis for Imaging
Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2007 through 2015 (includes corresponding
Graph/Chart)
- Table 28: US Historic Review for Imaging Agents by Product Segment -
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 29: US 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
16. CANADA
- A. Market Analysis
- Outlook
- Diagnostic Equipment Market
- LOCM Products Approved in Canada
- B. Market Analytics
- Table 30: Canadian Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment- Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 31: Canadian Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 32: Canadian 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
17. JAPAN
- A. Market Analysis
- Outlook
- Reimbursement Issues
- B. Market Analytics
- Table 33: Japanese Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 34: Japanese Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 35: Japanese 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
18. EUROPE
- A. Market Analysis
- Outlook
- Trends
- Reimbursement
- Outsourcing of Imaging Diagnostics
- Distribution Structure
- Direct Sales
- License Agreements
- Distribution Agreements
- A Price Sensitive Market
- Macro Environment
- Germany
- France
- Spain & Italy
- Scandinavia
- B. Market Analytics
- Table 36: European Recent Past, Current & Future Analysis for
Imaging Agents by Geographic Region - France, Germany, UK, Italy, Spain,
Russia and Rest of Europe Markets Independently Analyzed with Annual Sales
in US$ Million for Years 2007 through 2015 (includes corresponding
Graph/Chart)
- Table 37: European Historic Review for Imaging Agents by Geographic
Region - France, Germany, UK, Italy, Spain, Russia and Rest of Europe
Markets Independently Analyzed with Annual Sales Figures in US$ Million for
Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 38: European 11-Year Perspective for Imaging Agents by
Geographic Region - Percentage Breakdown of Dollar Sales for France,
Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart)
- Table 39: European Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 40: European Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 41: European 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
18a. FRANCE
- A. Market Analysis
- Outlook
- Growth Stimulants
- B. Market Analytics
- Table 42: French Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 43: French Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 44: French 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) & Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
18b. GERMANY
- A. Market Analysis
- B. Market Analytics
- Table 45: German Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 46: German Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 47: German 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
18c. ITALY
- Market Analysis
- Table 48: Italian Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 49: Italian Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 50: Italian 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
18d. THE UNITED KINGDOM
- A. Market Analysis
- B. Market Analytics
- Table 51: UK Recent Past, Current & Future Analysis for Imaging
Agents by Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Markets Independently Analyzed with Annual
Sales in US$ Million for Years 2007 through 2015 (includes corresponding
Graph/Chart)
- Table 52: UK Historic Review for Imaging Agents by Product Segment -
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 53: UK 11-Year Perspective for Imaging Agents by Product
Segment Percentage Breakdown of Dollar Sales for Contrast Media (X-ray, MRI
and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart)
18e. SPAIN
- Market Analysis
- Table 54: Spanish Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 55: Spanish Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 56: Spanish 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
18f. RUSSIA
- Market Analysis
- Table 57: Russian Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment -Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 58: Russian Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 59: Russian 11-Year Perspective for Imaging Agents by Product
Segment - Percentage Breakdown of Dollar Sales for Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for Years
2005, 2010 & 2015 (includes corresponding Graph/Chart)
18g. REST OF EUROPE
- Market Analysis
- Table 60: Rest of Europe Recent Past, Current & Future Analysis
for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 61: Rest of Europe Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 62: Rest of Europe 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
19. ASIA-PACIFIC
- A. Market Analysis
- Outlook
- MRI Market in Asia
- ANSTO: Leading the Radiopharmaceuticals Market
- India - A High Potential Market
- B. Market Analytics
- Table 63: Asia-Pacific Recent Past, Current & Future Analysis
for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 64: Asia-Pacific Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 65: Asia-Pacific 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
20. THE MIDDLE EAST
- Market Analysis
- Table 66: Middle East Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 67: Middle East Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 68: Middle East 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
21. LATIN AMERICA
- A. Market Analysis
- Private Sector Boosts Healthcare Segment
- B. Market Analytics
- Table 69: Latin American Recent Past, Current & Future Analysis
for Imaging Agents by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals Markets Independently
Analyzed with Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart)
- Table 70: Latin American Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding Graph/Chart)
- Table 71: Latin American 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic Radiopharmaceuticals Markets for
Years 2005, 2010 & 2015 (includes corresponding Graph/Chart)
COMPETITIVE LANDSCAPE
|
 |
